CDC Foundation Launches TINA, an Innovative Virtual Tool to Improve Cancer Patient-Provider Conversations about Infection Risk

The CDC Foundation has launched the first educational tool using virtual human technology to improve patient-provider conversations about a side effect of chemotherapy that may increase infection risk, known as neutropenia. This innovative new resource is part of the Preventing Infections in Cancer Patients (PICP) program, which has been led by the Centers for Disease Control and Prevention (CDC) and the CDC Foundation since 2009, with financial support from Amgen. Patient-clinician communication plays an important role in optimizing health outcomes, and is especially important in the cancer setting due to…

Read More